Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colonic Neoplasms × Fulvestrant × Clear all

Sponsor

Conditions

Breast Neoplasms 93 Neoplasms 12 Neoplasm Metastasis 12 Hereditary Sensory and Autonomic Neuropathies 3 Advanced Breast Cancer 3 Recurrence 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Solid Malignancies 1 Recurrent Uterine Corpus Carcinoma 1 Neoplasms by Site 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Hyperglycemia 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hormone Receptor Positive Breast Cancer 1 HER2-positive Breast Cancer 1 Exanthema 1 Estrogen Receptor-positive Breast Cancer 1 Carcinoma, Ovarian Epithelial 1 Breast Diseases 1 Breast Cancer Metastatic 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1

Interventions

Leucovorin 35 Fluorouracil 33 Oxaliplatin 31 Bevacizumab 29 Irinotecan 28 Cetuximab 21 Capecitabine 16 Panitumumab 13 IFL protocol 6 Folfox protocol 6 Nivolumab 5 Immunohistochemistry 5 pembrolizumab 4 Ramucirumab 4 Radiotherapy 4 Gene Expression Profiling 4 Floxuridine 4 dehydroftorafur 3 aflibercept 3 Surgical Procedures, Operative 3 Radiosurgery 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Gemcitabine 3 Fluorodeoxyglucose F18 3 Fentanyl 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 Celecoxib 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡